GKIM
ZBH icon

GW&K Investment Management’s Zimmer Biomet ZBH Stock Holding History

GW&K Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Sell
80
-1
-1% -$92 ﹤0.01% 917
2025
Q4 		$7K Buy
81
+13
+19% +$1.23K ﹤0.01% 908
2025
Q3 		$7K Sell
68
-28
-29% -$2.77K ﹤0.01% 911
2025
Q2 		$9K Sell
96
-11
-10% -$1.06K ﹤0.01% 869
2025
Q1 		$12K Sell
107
-12
-10% -$1.28K ﹤0.01% 772
2024
Q4 		$13K Buy
119
+3
+3% +$322 ﹤0.01% 724
2024
Q3 		$13K Buy
116
+8
+7% +$873 ﹤0.01% 720
2024
Q2 		$12K Buy
108
+5
+5% +$589 ﹤0.01% 696
2024
Q1 		$14K Buy
103
+22
+27% +$2.75K ﹤0.01% 613
2023
Q4 		$10K Buy
81
+3
+4% +$335 ﹤0.01% 689
2023
Q3 		$9K Buy
78
+8
+11% +$1.02K ﹤0.01% 651
2023
Q2 		$10K Buy
+70
New +$9.51K ﹤0.01% 620
2022
Q3 		– Sell
-21
Closed -$2K – 835
2022
Q2 		$2K Buy
21
+5
+31% +$593 ﹤0.01% 785
2022
Q1 		$2K Buy
+16
New +$1.93K ﹤0.01% 738

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GW&K Investment Management's ZBH Position: Q1 2026 in Review

GW&K Investment Management reduced its Zimmer Biomet (ZBH) stake by 1.2% in Q1 2026, selling an estimated $92 and leaving 80 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

GW&K Investment Management first reported a position in ZBH in Q1 2022 and has held it in 14 quarters since. The position peaked at $14K in Q1 2024. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • GW&K Investment Management held 80 shares of Zimmer Biomet worth $7K as of Q1 2026.
  • GW&K Investment Management sold 1 Zimmer Biomet share in Q1 2026, an estimated $92.
  • Zimmer Biomet made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #917 holding.
  • GW&K Investment Management first reported a position in Zimmer Biomet in Q1 2022 and has held it in 14 quarters since.
  • GW&K Investment Management's Zimmer Biomet position peaked at $14K in Q1 2024.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.